MedPath
TGA Approval

Adevaya Australia NMN+ 200,000 mcg (407993)

407993

Adevaya Australia NMN+ 200,000 mcg

Adevaya Pharmaceuticals Pty Ltd

April 24, 2023

Medicine

Medicine

Active

Listed - Exempt

Active Ingredients

nicotinamide mononucleotide

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Adevaya Australia NMN+ 200,000 mcg (407993) - TGA 批准文号 | MedPath